BPC 157 for athletes and injury treatment: Science, safety, and legal concerns FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC BPC 157 Banned: Key Facts on the Latest FDA Decision The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Moves to Reevaluate Several Peptides American Med Spa Association